← Open Payments lookup

MELISSA KOONCE: Open Payments

NPI 1811415540 · BLYTHEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,845 in 92 payments from 29 companies in 2025. Trend: 2023 $1,598 · 2024 $1,600 · 2025 $1,845

Food & beverage: $1,570Education: $275
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$277
Incyte Corporation8$196
Gilead Sciences, Inc.3$129
Lilly USA, LLC5$121
Janssen Biotech, Inc.5$112
AstraZeneca Pharmaceuticals LP6$106
Takeda Pharmaceuticals U.S.A., Inc.5$101
PUMA BIOTECHNOLOGY, INC.5$82
Regeneron Healthcare Solutions, Inc.3$73
Ipsen Biopharmaceuticals, Inc4$65

Products named: KISQALI, Trodelvy, ENHERTU, NERLYNX, Fabhalta, LIBTAYO, Onivyde, VENCLEXTA.

Industry payments across AR — which companies pay providers there.